Bạn đã lưu vào mục danh sách Bạn đã hủy mục danh sách Xin vui lòng đợi trong chốc lát... Trang cá nhân Bạn vui lòng nhập vào thông tin tìm kiếm. Xin chào, khách! Đăng nhập Đăng xuất Toàn bộ

Tin tức

DANH MỤC BÀI BÁO QUỐC TẾ THÁNG 3 NĂM 2020

Tập hợp những bài báo về lĩnh vực y học hay và nổi bật mới xuất bản trong tháng 03 năm 2020. Đặc biệt là dịch bệnh viêm phổi do virus Corona ( Covid-19). Căn bệnh đã xuất hiện ở thành phố Vũ Hán, tỉnh Hồ Bắc của Trung Quốc và lan rộng ra 199 quốc gia và vùng lãnh thổ, đã chuyển hướng tâm dịch sang Mỹ và các nước Châu âu như Ý, Tây Ban Nha, Pháp, Đức, Anh,...với 720.000 ca nhiễm bệnh, ít nhất có 34.000 ca tử vong trên toàn cầu tính đến ngày 30/3/2020.

  

                                                                         DANH MỤC BÀI BÁO QUỐC TẾ THÁNG 03/2020
STT                     TÊN BÀI BÁO                                          LINK BÀI BÁO TÊN BÁO/TẠP CHÍ TÁC GIẢ NGÀY ĐĂNG
1 Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32170560 Frontiers of medicine Zou X1, Chen K1, Zou J1, Han P2, Hao J3, Han Z4. 12/3/2020
2 The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32169119 Military Medical Research Guo YR1, Cao QD2, Hong ZS3, Tan YY1, Chen SD1, Jin HJ1, Tan KS4, Wang DY5, Yan Y6,7 13/3/2020
3 Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32167747 ACS chemical neuroscience Baig AM1, Khaleeq A1, Ali U2, Syeda H3. 13/3/2020
4 The establishment of reference sequence for SARS-CoV-2 and variation analysis http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32167180 Journal of medical virology Wang C1,2,3, Liu Z1,2, Chen Z2, Huang X2, Xu M1,2, He T1,2, Zhang Z1,2,4. 13/3/2020
5 Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32165386 Microbiology resource announcements Sah R#1, Rodriguez-Morales AJ#2,3, Jha R4, Chu DKW5, Gu H5, Peiris M5, Bastola A6, Lal BK7, Ojha HC7, Rabaan AA8, Zambrano LI9, Costello A10, Morita K11, Pandey BD6, Poon LLM 12/3/2020
6 The cyanobacterial saxitoxin exacerbates neural cell death and brain malformations induced by Zika virus https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0008060 Plos Neglected tropical diseases Carolina da S. G. Pedrosa 12/3/2020
7 Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19? http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32179150 International journal of antimicrobial agents Baron SA1, Devaux C2, Colson P1, Raoult D3, Rolain JM4. 13/3/2020
8 Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32178975 Clinica chimica acta; international journal of clinical chemistry Lippi G1, Plebani M2, Michael Henry B3. 13/3/2020
9 Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32178593 Emerging microbes & infections Vankadari N1, Wilce JA1. 19/3/2020
10 A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32173110 Journal of critical care Cortegiani A1, Ingoglia G2, Ippolito M2, Giarratano A2, Einav S3. 10/3/2020
11 Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32173576 International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases Liu F1, Xu A1, Zhang Y2, Xuan W3, Yan T3, Pan K1, Yu W1, Zhang J4. 13/3/2020
12 Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32172228 Clinical chemistry and laboratory medicine Lippi G1, Simundic AM2, Plebani M3. 16/3/2020
13 Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32191676 Acta bio-medica : Atenei Parmensis Baglivo M1, Baronio M2, Natalini G3, Beccari T4, Chiurazzi P5, Fulcheri E6, Petralia PP7, Michelini S8, Fiorentini G9, Miggiano GA10, Morresi A11, Tonini G12, Bertelli M13. 19/3/2020
14 Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32191588 Radiology Li L1, Qin L1, Xu Z1, Yin Y1, Wang X1, Kong B1, Bai J1, Lu Y1, Fang Z1, Song Q1, Cao K1, Liu D1, Wang G1, Xu Q1, Fang X1, Zhang S1, Xia J1, Xia J1. 19/3/2020
15 Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32190890 American journal of clinical pathology Iwen PC1,2, Stiles KL2, Pentella MA3. 19/3/2020
16 A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32187464 The New England journal of Medicine Cao B1, Wang Y1, Wen D1, Liu W1, Wang J1, Fan G1, Ruan L1, Song B1, Cai Y1, Wei M1, Li X1, Xia J1, Chen N1, Xiang J1, Yu T1, Bai T1, Xie X1, Zhang L1, Li C1, Yuan Y1, Chen H1, Li H1, Huang H1, Tu S1, Gong F1, Liu Y1, Wei Y1, Dong C1, Zhou F1, Gu X1, Xu J1,  19/3/2020
17          
18          
19 Eleven Faces of Coronavirus Disease 2019. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32196678 Allergy Dong X1, Cao YY2, Lu XX3, Zhang JJ1, Du H3, Yan YQ4, Akdis CA5, Gao YD1. 20/3/2020
20 Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32194981 Cell discovery Liu J#1, Cao R#2, Xu M#1,3, Wang X1, Zhang H1,3, Hu H1,3, Li Y1,3, Hu Z1, Zhong W2, Wang M1. 18/3/2020
21 Public health measures to slow community spread of COVID-19. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32193550 The Journal of infectious diseases Cowling BJ1, Aiello A2. 20/3/2020
22 Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32207377 Emerging microbes & infections Nie J1, Li Q1,2, Wu J1,3, Zhao C1, Hao H1, Liu H1, Zhang L1, Nie L1, Qin H1, Wang M1, Lu Q1, Li X1, Sun Q1, Liu J1, Fan C4, Huang W1, Xu M5, Wang Y1, 25/3/2020
23 Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19). http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32205220 Clinical gastroenterology and hepatology  Luo S1, Zhang X2, Xu H1. 20/3/2020
24 Insights from nanomedicine into chloroquine efficacy against COVID-19. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32203437 Nature nanotechnology Hu TY1, Frieman M2, Wolfram J3,4,5,6. 23/3/2020
25 Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32200634 Journal of proteome research Zhang C, Zheng W, Huang X, Bell EW, Zhou X, Zhang Y. 24/3/2020
26 Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32200654 American journal of respiratory and critical care medicine Chang1,2, Mo G1, Yuan X1, Tao Y1, Peng X1, Wang F1, Xie L1, Sharma L3, Dela Cruz CS4, Qin E1. 23/3/2020
27 Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32204943 Vaccine Dayan GH1, Langevin E2, Gilbert PB3, Wu Y4, Moodie Z5, Forrat R6, Price B7, Frago C8, Bouckenooghe A9, Cortes M10, Noriega F11, DiazGranados CA12 20/3/2020
28 Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV https://www.nature.com/articles/s41467-020-15562-9 Nature Communications volume  Xiuyuan Ou, 27/3/2020
29 Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19 http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32221983 Journal of medical virology Cheng H1, Wang Y1, Wang GQ1,2, 27/3/2020
30 A Genomic Perspective on the Origin and Emergence of SARS-CoV-2. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32220310 cell Zhang YZ1, Holmes EC2. 26/3/2020
31 SARS-CoV-2: What do we know so far? http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32220035 Acta physiologica (Oxford, England)

Khedkar PH1, Patzak A1.

27/3/2020
32 Convalescent Plasma to Treat COVID-19: Possibilities and Challenges. http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32219429 JAMA Roback JD1, Guarner J2. 273/2020
33 Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19). http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32220033 Journal of internal medicine Wu J1,2, Li W3, Shi X1, Chen Z2, Jiang B4, Liu J5, Wang D6, Liu C7, Meng Y8, Cui L2, Yu J1, Cao H1,9, Li L1. 27/3/2020